LEI 213800TYYFXKYF3V2A23
ONCOINVENT ASA
Contract awards & public grants
EuroPean Training NetwoRks to TArget DAMPs and NETs: novel apprOaches in pRecision SepsIs pAtieNt care → BerGenBio AS
European Commission · NO · Grant · 2023-07-10
—
ONCOINVENT ASA — Integrated multiomic analyses of patients treated with Axl inhibitors to predict therapy response, clinical benefit and mechanism of action.
Norges forskningsråd · NO · Grant · 2020-01-01
NOK 2.34M
ONCOINVENT ASA — Molecular interactions important for Axl activation
Norges forskningsråd · NO · Grant · 2020-01-01
NOK 2.35M
ONCOINVENT ASA — Innovasjonstilskudd: Forsknings- og utviklingstilskudd
Innovasjon Norge · NO · Grant · 2019-12-13
€417,391
ONCOINVENT ASA — AXL as a therapeutic target in fibrosis; biology and biomarkers
Norges forskningsråd · NO · Grant · 2019-01-01
NOK 10.69M
ONCOINVENT ASA — Exploring the effects of Radium-224 in ovarian cancer
Norges forskningsråd · NO · Grant · 2019-01-01
NOK 2.01M
ONCOINVENT ASA — Innovasjonstilskudd: Forsknings- og utviklingstilskudd
Innovasjon Norge · NO · Grant · 2016-12-15
€2.09M
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.